Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Xiaofeng Chen
HEC Pharm R&D Co., Ltd. - Biologics Institute
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
63
SSRN CITATIONS
2
CROSSREF CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Novel GLP-1 and FGF21 Dual Agonist Has Therapeutic Potential for Diabetes and Non-Alcoholic Steatohepatitis
Number of pages: 49
Posted: 23 Oct 2020
Qi Pan
,
Shushan Lin
,
Yu Li
,
Liang Liu
,
Xiaoping Li
,
Xianglei Gao
,
Jiangyu Yan
,
Baohua Gu
, Xiaofeng Chen,
Wenjia Li
,
Xinfa Tang
,
Chao Chen
and
Lixin Guo
Beijing Hospital - National Center of Gerontology, Department of Endocrinology, HEC Pharm R&D Co., Ltd. - Biologics Institute, HEC Pharm R&D Co., Ltd. - Department of Pharmacology, HEC Pharm R&D Co., Ltd. - Department of Pharmacology, HEC Pharmaceutical Co., Ltd. - Department of Biologics, HEC Pharmaceutical Co., Ltd. - Department of Biologics, HEC Pharmaceutical Co., Ltd. - Department of Biologics, HEC Pharm R&D Co., Ltd. - Biologics Institute, HEC Pharm R&D Co., Ltd. - Biologics Institute, HEC Pharm R&D Co., Ltd. - Biologics Institute, HEC Pharm R&D Co., Ltd. - Biologics Institute, HEC Pharmaceutical Co., Ltd. - Department of Biologics and Beijing Hospital - National Center of Gerontology, Department of Endocrinology
Downloads
63
(627,735)
View PDF
Download
Abstract:
Diabetes, NASH, FGF21, GLP-1, Fusion Protein
Feedback